List of works - Matthew M. Heeney

Acquired immune cytopenias post-cardiac transplantation respond to rituximab.

scientific article

Bacteremia risk and outpatient management of febrile patients with sickle cell disease.

scientific article published on 13 May 2013

Cefepime-induced neutropenia in a teenager

scientific article published in November 2008

Chemical and functional analysis of hydroxyurea oral solutions.

scientific article

Childhood autoimmune cytopenia secondary to unsuspected common variable immunodeficiency

scientific article

Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry

scientific article

Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain.

scientific article published on March 2009

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways ⬇️

scientific article

Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission.

scientific article published in January 2010

Definitions of the phenotypic manifestations of sickle cell disease

scientific article published on January 2010

Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)

scientific article published on 01 August 2018

Hemoglobin SE disease: a concise review.

scientific article published on July 2007

Hemoglobinopathies mimicking Hb S/β-thalassemia: Hb S/S with α-thalassemia and Hb S/Volga

scientific article published on 01 May 2006

High-throughput matrix-assisted laser desorption ionization-time-of-flight mass spectrometry method for quantification of hepcidin in human urine

scientific article

Hydroxyurea for children with sickle cell disease

scientific article published on February 2010

Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children.

scientific article

Increased expression of anti-apoptosis genes in peripheral blood cells from patients with paroxysmal nocturnal hemoglobinuria.

scientific article

Iron clad: iron homeostasis and the diagnosis of hereditary iron overload.

scientific article

Iron disorders

scientific article published on 01 August 2014

Iron homeostasis and inherited iron overload disorders: an overview

scientific article

Iron-refractory iron deficiency anemia (IRIDA).

scientific article

Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease

scientific article

Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant RhAG F65S

scientific article (publication date: December 2011)

Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)

scientific article

Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD)

scientific article

Mutations in the iron-sulfur cluster biogenesis protein HSCB cause congenital sideroblastic anemia

scientific article published on 07 July 2020

Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency

scientific article published on 12 June 2018

Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.

scientific article published in April 2009

Platelet activation and inhibition in sickle cell disease (pains) study.

scientific article published on 7 March 2013

Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study.

scientific article published on January 2015

Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion.

scientific article published on 3 September 2007

Resolution of cerebral artery stenosis in a child with sickle cell anemia treated with hydroxyurea.

scientific article published in February 2010

Systemic corticosteroids in acute chest syndrome: friend or foe?

scientific article published on 31 October 2013

The effect of iron chelation therapy on overall survival in sickle cell disease and β-thalassemia: A systematic review.

scientific article published on 10 April 2018

X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations

scientific article

List of works by Matthew M. Heeney

Acquired immune cytopenias post-cardiac transplantation respond to rituximab.

Bacteremia risk and outpatient management of febrile patients with sickle cell disease.

Cefepime-induced neutropenia in a teenager

Chemical and functional analysis of hydroxyurea oral solutions.

Childhood autoimmune cytopenia secondary to unsuspected common variable immunodeficiency

Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry

Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain.

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways ⬇️

Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission.

Definitions of the phenotypic manifestations of sickle cell disease

Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)

Hemoglobin SE disease: a concise review.

Hemoglobinopathies mimicking Hb S/β-thalassemia: Hb S/S with α-thalassemia and Hb S/Volga

High-throughput matrix-assisted laser desorption ionization-time-of-flight mass spectrometry method for quantification of hepcidin in human urine

Hydroxyurea for children with sickle cell disease

Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children.

Increased expression of anti-apoptosis genes in peripheral blood cells from patients with paroxysmal nocturnal hemoglobinuria.

Iron clad: iron homeostasis and the diagnosis of hereditary iron overload.

Iron disorders

Iron homeostasis and inherited iron overload disorders: an overview

Iron-refractory iron deficiency anemia (IRIDA).

Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease

Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant RhAG F65S

Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)

Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD)

Mutations in the iron-sulfur cluster biogenesis protein HSCB cause congenital sideroblastic anemia

Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency

Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.

Platelet activation and inhibition in sickle cell disease (pains) study.

Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study.

Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion.

Resolution of cerebral artery stenosis in a child with sickle cell anemia treated with hydroxyurea.

Systemic corticosteroids in acute chest syndrome: friend or foe?

The effect of iron chelation therapy on overall survival in sickle cell disease and β-thalassemia: A systematic review.

X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations